Search clinical trials for: Dopamine Agonists

Total 16698 results

Woman's Health University Hospital, Egypt

Completed

Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.

Health Education

Egypt
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Rennes University Hospital

Completed

Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease (APO-TEP)

Parkinsons's Disease

France
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); Columbia University; Emory University and other collaborators

Terminated

1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

Depression | Cognitive Impairment | Gait Impairment

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Terminated

L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

Depression | Major Depressive Disorder | Dysthymia

United States
Luye Pharma Group Ltd.
Parexel

Completed

A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD

Parkinson Disease

China
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" (SWITCH)

Schizophrenia

Italy
Titan Pharmaceuticals

Terminated

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Parkinson Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Bipolar Disorder

United States, South Africa, Brazil, Russian Federation, France, Czechia, Croatia, India, Bulgaria
Knopp Biosciences

Completed

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma (EXHALE-1)

Asthma | Eosinophilic Asthma

United States
Serina Therapeutics

Active, not recruiting

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Parkinson's Disease

United States
Genuine Research Center, Egypt
P&C Labs, Egypt

Completed

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Healthy

Egypt
Pharma Two B Ltd.

Completed

Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease

Parkinson's Disease

United States, Israel
Policlinico Hospital

Completed

Vasoactive-inotropic Support and Levosimendan Use After Lung Transplantation (VASO_LUTX)

Lung Transplant; Complications

Italy
Montreal Heart Institute
Canadian Cardiovascular Society

Withdrawn

Bromocriptine in the Treatment of Peripartum Cardiomyopathy (BRO-HF)

Peripartum Cardiomyopathy

Canada
University of Kansas Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Individualizing Pharmacotherapy for African American Smokers

Smoking Cessation

United States
First Affiliated Hospital of Zhejiang University
Hongguan biological pharmaceutical co.

Terminated

Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets (PLKS-BE)

Parkinson's Disease

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Nasopharyngeal Carcinoma | Current Smoker | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma

United States
Pharma Two B Ltd.

Completed

A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

Parkinson Disease | Early Parkinson's Disease

United States, Canada, Germany, Spain
Baylor College of Medicine
UCB Pharma

Completed

Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study

Parkinson's Disease

United States
Haukeland University Hospital

Active, not recruiting

Myocardial Deformation Before and After Birth

Newborn Morbidity | Maternal Obesity | Myocardial Dysfunction

Norway
University Health Network, Toronto
University of British Columbia; McGill University; Centre for Addiction and Mental... and other collaborators

Completed

Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

Major Depressive Disorder

Canada
Yale University

Completed

Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans

Cocaine Dependence

United States
University of Washington

Withdrawn

Research on Translational Outcomes of Alcohol (Project RETRO)

Alcohol Drinking
Impax Laboratories, LLC

Completed

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Parkinson's Disease (Disorder)

United States, Czechia, France, Italy, Spain, Germany, Poland, United Kingdom
Ain Shams University

Completed

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Analgesia | Anesthesia | Hysterotomy

Egypt
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder (STEP-A)

Attention Deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Withdrawn

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Major Depressive Disorder (MDD)
Rush University Medical Center

Completed

Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock

Septic Shock

United States
Pulmatrix Inc.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults

Healthy

Australia
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING) (GENTSMOKING)

Smoking Cessation | Genetic Predisposition

Brazil
AbbVie
IQVIA, formerly Quintiles

Completed

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

Advanced Parkinson's Disease

United Kingdom, Czechia, United States, Australia, Canada, Israel, New Zealand, Poland, Portugal, Russian Federation, Thailand
Washington University School of Medicine
Patient-Centered Outcomes Research Institute; National Institute of Mental...

Completed

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM)

Major Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric Depression

United States, Canada
Boston Medical Center

Withdrawn

Duloxetine Tibial Plateau

Pain, Postoperative | Tibial Plateau Fracture

United States
Pfizer

Completed

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Major Depression

Korea, Republic of
HaEmek Medical Center, Israel

Completed

Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline

Lactation Suppressed

Israel
Denovo Biopharma LLC

Completed

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Schizophrenia

United States, Mexico, Germany, Russian Federation
Vanderbilt University Medical Center

Completed

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

Cirrhosis | Muscle Cramp

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)

Borderline Personality Disorder

United States
Population Health Research Institute

Completed

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS)

Restless Legs Syndrome | End Stage Renal Disease

Canada
Medical College of Wisconsin

Terminated

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants (Fenaki)

Acute Kidney Injury (AKI) | Patent Ductus Arteriosus (PDA)

United States
Denovo Biopharma LLC

Completed

A Study of Safety and Tolerability in Subjects With Schizophrenia

Schizophrenia

United States
Shanghai Mental Health Center

Withdrawn

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder
Future University in Egypt

Completed

Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Denovo Biopharma LLC

Terminated

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Schizophrenia

Germany, Spain, United States, Belgium, France, Sweden, Austria, Poland, Puerto Rico, Romania
University of North Carolina, Chapel Hill
American Diabetes Association

Completed

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

Overweight and Obesity | Eating Behavior

United States
King's College London
Shire

Active, not recruiting

Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents (AGUALIS)

ADHD

United Kingdom
University Hospital Freiburg

Withdrawn

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

Therapy-resistant Depression

Germany
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
University of Alberta

Terminated

Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD

Restless Legs Syndrome | End Stage Renal Disease

Canada

Search clinical trials for: Dopamine Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations